Related Experiment Video
Updated: Aug 19, 2026

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
[Risk factor for antibiotic-associated diarrhea. A review of the literature]
1Department of Medicinal Chemistry, School of Pharmacy, University of Washington, Seattle, USA.
Abstract:
Antibiotic associated diarrhea (AAD) is a common adverse reaction to most types of antibiotics with frequencies ranging from 5-39%, depending upon the specific type of antibiotic and the presence of other risk factors. The pathogenesis of antibiotic associated diarrhea is mediated through the disruption of the normal flora and overgrowth of pathogens or through metabolic imbalances. Beside risk factors associated with the type and duration of antibiotic therapy, host factors include the extremes of age (< 6 years or > 65 years), severe underlying disease, presence of other chronic intestinal conditions, immunosuppression, prior history of AAD and exposures during recent hospitalizations (surgery, nasogastric tube feeding). Factors which have not been significantly associated with antibiotic associated diarrhea include gender, dose or route of the inciting antibiotic and inflammatory bowel disease. The clinical impact of AAD is reflected by potential severity of the illness (PMC), possible consequences of the disruption in the treatment of the primary infection, higher medical costs, increased hospital stays and increased rates of morbidity and mortality. The key to decreasing these consequences is prompt diagnosis followed by effective treatment and institution of control measures and preventive treatments in patients at risk.
Insights
Antibiotic-associated diarrhea (AAD) is a frequent side effect of antibiotics, occurring in 5-39% of patients. Prompt diagnosis and treatment are crucial to mitigate its severe health and economic impacts.
Area of Science:
- Gastroenterology
- Infectious Diseases
- Pharmacology
Context:
- Antibiotic-associated diarrhea (AAD) is a common adverse effect of antibiotic therapy.
- It affects 5-39% of patients, influenced by antibiotic type and risk factors.
- Pathogenesis involves gut flora disruption and pathogen overgrowth.
Purpose:
- To review the risk factors, pathogenesis, clinical impact, and management of AAD.
- To highlight the importance of prompt diagnosis and effective treatment strategies.
Summary:
- Risk factors include antibiotic type, duration, extremes of age, severe illness, immunosuppression, and prior AAD history.
- Factors not significantly associated with AAD are gender, dose, route of antibiotic, and inflammatory bowel disease.
- AAD can lead to severe illness, treatment complications, increased costs, and prolonged hospital stays.
Impact:
- Effective management of AAD can reduce morbidity, mortality, and healthcare costs.
- Preventive strategies and prompt treatment are essential for at-risk patients.
- Understanding AAD pathogenesis aids in developing targeted interventions.
More Related Videos
08:33Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment
Published on: November 17, 2018
03:25Ginger Moxibustion, A Non-pharmacological Treatment, for Diarrhea in Patients with Chronic Obstructive Pulmonary Disease
Published on: December 27, 2024
Related Concept Videos
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Dysbiosis of the Gut Microbiota
Microbiota Modulation by Antibiotics
Bacterial Gastroenteritis
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance